公司概覽
業務類別 Biotechnology
業務概覽 Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs. Currently, the company has two distinct clinical development programs, one targeting EoE and the second targeting chronic Osteoarthritis pain in the knee and has completed a Phase 2b clinical trial with EP-104IAR in knee OA.
公司地址 201 2067 Cadboro Bay Road, Victoria, BC, CAN, V8R 5G4
電話號碼 +1 250 590-3968
傳真號碼 +1 250 590-2588
公司網頁 https://www.eupraxiapharma.com
員工數量 49
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Paul Brennan Chief Business Officer 美元 253.97K 13/03/2026
Dr. Mark Kowalski, M.D.,Pd.D Chief Medical Officer 美元 435.00K 13/03/2026
Dr. James A. Helliwell, M.D. Chief Executive Officer and Director 美元 429.25K 13/03/2026
Dr. Amanda Malone Chief Scientific Officer and Chief Operating Officer 美元 329.09K 13/03/2026
Mr. Alexander Rothwell Chief Financial Officer 美元 287.95K 13/03/2026
 
董事會成員
董事會 職務 更新日期
Dr. Richard M. Glickman,L.L.D. Independent Director 13/03/2026
Mr. Paul L. Geyer, P. Eng. Independent Director 13/03/2026
Mr. Joseph Freedman, L.L.B.,M.B.A. Director 13/03/2026
Mr. Robert B. Bazemore, Jr Director 13/03/2026
Dr. Simon Pimstone, F.R.C.P.C,M.D.,PhD Chairman of the Board 13/03/2026
Mr. John S. Montalbano, C.F.A. Independent Director 13/03/2026
Ms. Amy Pott Director 13/03/2026
Dr. James A. Helliwell, M.D. Chief Executive Officer and Director 13/03/2026
Dr. Michael Wilmink, M.D. Independent Director 13/03/2026
 
所屬ETF (更新日期: 14/11/2026 03:51)
代號 名稱 佔比% ▼ 持有日期
GWXState Street® SPDR® S&P® Intl Sm Cp ETF0.07%30/10/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.